London: Scientists have claimed that a "molecular scalpel" has shown promising results in patients suffering from Duchenne muscular dystrophy, a deadly muscle wasting condition. The gene for the protein dystrophin is damaged in people with Duchenne muscular dystrophy. Now, a drug trial on 19 children, published in `The Lancet` journal, used the new "scalpel" to remove damage and restore dystrophin production. Duchenne muscular dystrophy affects one in every 3,500 newborn boys. Throughout life the muscle wastes away and children can need a wheelchair by the age of 10. The condition can become life-threatening before age of 30, when it affects the muscles needed to breathe and pump blood around the body.
FM Arun Jaitley presents budget in Parliament
What common people want from Modi govt`s budget
The history of Indian Budget
Marrow Donor Registry of India launches Gujarat chapter